GROUP ONE TRADING, L.P. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$964,833
+334.3%
84,118
+858.4%
0.00%
+200.0%
Q2 2023$222,146
-75.2%
8,777
-68.4%
0.00%
-66.7%
Q1 2023$895,213
-59.6%
27,793
-76.9%
0.00%
-40.0%
Q4 2022$2,216,861
+3363.8%
120,090
+2489.8%
0.01%
Q2 2022$64,000
-83.8%
4,637
-77.2%
0.00%
Q1 2022$396,000
+4300.0%
20,330
+6333.5%
0.00%
Q3 2021$9,000
-96.2%
316
-96.1%
0.00%
Q2 2021$238,000
+31.5%
8,038
+23.9%
0.00%
Q1 2021$181,000
-46.8%
6,487
-45.9%
0.00%
-100.0%
Q4 2020$340,000
+7.9%
11,987
-4.3%
0.00%0.0%
Q3 2020$315,000
+1752.9%
12,521
+1717.3%
0.00%
Q2 2020$17,000
+1600.0%
689
+943.9%
0.00%
Q1 2020$1,000
-99.2%
66
-99.1%
0.00%
-100.0%
Q4 2019$121,000
+3933.3%
7,475
+3656.3%
0.00%
Q2 2019$3,0000.0%1990.0%0.00%
Q1 2019$3,000199
+1558.3%
0.00%
Q1 2018$0
-100.0%
12
-93.9%
0.00%
Q4 2017$7,000
-75.0%
198
-80.2%
0.00%
Q3 2017$28,000
+64.7%
1,000
+24.8%
0.00%
Q4 2016$17,000
-41.4%
801
-55.5%
0.00%
Q3 2016$29,000
+52.6%
1,801
+26.7%
0.00%
Q2 2016$19,000
-74.3%
1,421
-66.3%
0.00%
-100.0%
Q1 2016$74,000
-70.4%
4,221
-42.3%
0.00%
-66.7%
Q4 2015$250,000
+1090.5%
7,321
+945.9%
0.00%
Q3 2015$21,000
-56.2%
700
-69.6%
0.00%
-100.0%
Q1 2015$48,0002,3000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders